Sutro Biopharma, a drug development and manufacturing company headquartered in South San Francisco, is transforming biotherapeutics discovery with a novel platform for cell-free protein synthesis ...

Ribosomes are the sites in a cell in which protein synthesis takes place. Cells have many ribosomes, and the exact number depends on how active a particular cell is in synthesizing proteins.

Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients with abnormal protein synthesis are treated to produce a healthy protein.

The global difficult-to-express protein market is on track for remarkable expansion, with a projected compound annual growth rate (CAGR) of 8.5% from 2024 to 2034, according to a recent report by ...

They described it as a modular cell-free protein biosensor platform. Cell-free means the team uses the kind of machinery found in cells but engineers it in the lab rather than in cells ...

The team's modular cell-free protein biosensor platform produces a simple color output based on the amount of protein detected in a sample. That makes it easy for any user, without specialized ...